載入...
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Targeted cancer therapies, which act on specific cancer-associated molecular targets, are predominantly inhibitors of oncogenic kinases. While these drugs have achieved some clinical success, the inactivation of kinase signaling via stimulation of endogenous phosphatases has received minimal attenti...
Na minha lista:
發表在: | J Clin Invest |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
American Society for Clinical Investigation
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451217/ https://ncbi.nlm.nih.gov/pubmed/28504649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI89548 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|